Clinical innovation has never moved faster. Tools like single-arm designs, novel surrogates, and ada...
Read moreSurrogate Endpoints in HTA Decision-Making The need to stay ahead of competitors and offset losses f...
Read moreThe key to pricing success for any pharmaceutical product is effectively exhibiting the asset’...
Read moreWhether you’re in drug development, market access, or health economics, early scientific advic...
Read moreCharlie Hewitt from Remap Consulting initiated today’s session by providing a description of the c...
Read moreBack in January this year, we summarised the key trends our market access experts believed would dom...
Read moreSwitzerland is set to make significant changes in 2024 to enhance access to medicines, cut costs, an...
Read moreConduct a rapid pricing and market access (P&MA) assessment across the US and EU5 in order to determ...
Read moreOur client wanted to gain an understanding of payer willingness to pay and determine the likely clin...
Read moreOur client wanted to understand the clinical and economic evidence requirements that drive payer dec...
Read more